Lantheus inks Ablavar contract with Amerinet

Lantheus Medical Imaging of North Billerica, MA, has signed its first national contract to supply its Ablavar MR angiography contrast agent to group purchasing organization Amerinet of St. Louis.

The agreement is effective May 1 and makes Ablavar available to more than 2,500 acute care hospitals and 25,000 alternate care members in the Amerinet network.

Ablavar is indicated for use as a contrast agent in MR angiography to evaluate aortoiliac occlusive disease in adults with known or suspected peripheral vascular disease.

Related Reading

Lantheus receives Mo-99 from Europe, May 21, 2010

Lantheus touts SNM papers, May 19, 2010

Lantheus taps new VP, April 22, 2010

Lantheus touts data on PET agent at ACC show, March 18, 2010

Lantheus signs Spurr, February 17, 2010

Copyright © 2010 AuntMinnie.com

Page 1 of 374
Next Page